nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7—Tamoxifen—pancreatic cancer	0.0705	0.0936	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0705	0.0936	CbGbCtD
Alprazolam—CYP3A7—Irinotecan—pancreatic cancer	0.0542	0.0719	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0542	0.0719	CbGbCtD
Alprazolam—CYP3A5—Tamoxifen—pancreatic cancer	0.0529	0.0703	CbGbCtD
Alprazolam—CYP3A5—Erlotinib—pancreatic cancer	0.045	0.0597	CbGbCtD
Alprazolam—CYP3A5—Irinotecan—pancreatic cancer	0.0406	0.0539	CbGbCtD
Alprazolam—CYP3A7—Docetaxel—pancreatic cancer	0.0397	0.0527	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0397	0.0527	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0395	0.0525	CbGbCtD
Alprazolam—CYP3A7—Sunitinib—pancreatic cancer	0.0395	0.0525	CbGbCtD
Alprazolam—CYP2C9—Tamoxifen—pancreatic cancer	0.0355	0.0471	CbGbCtD
Alprazolam—CYP3A5—Docetaxel—pancreatic cancer	0.0298	0.0395	CbGbCtD
Alprazolam—CYP3A5—Sunitinib—pancreatic cancer	0.0296	0.0394	CbGbCtD
Alprazolam—CYP2C9—Fluorouracil—pancreatic cancer	0.0261	0.0347	CbGbCtD
Alprazolam—CYP3A4—Tamoxifen—pancreatic cancer	0.0206	0.0274	CbGbCtD
Alprazolam—CYP3A4—Erlotinib—pancreatic cancer	0.0175	0.0233	CbGbCtD
Alprazolam—CYP3A4—Irinotecan—pancreatic cancer	0.0158	0.021	CbGbCtD
Alprazolam—CYP3A4—Docetaxel—pancreatic cancer	0.0116	0.0154	CbGbCtD
Alprazolam—CYP3A4—Sunitinib—pancreatic cancer	0.0116	0.0153	CbGbCtD
Alprazolam—CYP3A4—Doxorubicin—pancreatic cancer	0.00865	0.0115	CbGbCtD
Alprazolam—Body temperature increased—Irinotecan—pancreatic cancer	0.000242	0.000982	CcSEcCtD
Alprazolam—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000242	0.00098	CcSEcCtD
Alprazolam—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000241	0.000975	CcSEcCtD
Alprazolam—Muscular weakness—Doxorubicin—pancreatic cancer	0.000237	0.000961	CcSEcCtD
Alprazolam—Vomiting—Sunitinib—pancreatic cancer	0.000237	0.000959	CcSEcCtD
Alprazolam—Body temperature increased—Gemcitabine—pancreatic cancer	0.000236	0.000956	CcSEcCtD
Alprazolam—Dysuria—Epirubicin—pancreatic cancer	0.000235	0.000952	CcSEcCtD
Alprazolam—Rash—Sunitinib—pancreatic cancer	0.000235	0.000951	CcSEcCtD
Alprazolam—Dermatitis—Sunitinib—pancreatic cancer	0.000234	0.00095	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000234	0.000946	CcSEcCtD
Alprazolam—Urticaria—Fluorouracil—pancreatic cancer	0.000233	0.000945	CcSEcCtD
Alprazolam—Headache—Sunitinib—pancreatic cancer	0.000233	0.000944	CcSEcCtD
Alprazolam—Syncope—Docetaxel—pancreatic cancer	0.000233	0.000943	CcSEcCtD
Alprazolam—Dysphagia—Doxorubicin—pancreatic cancer	0.000233	0.000942	CcSEcCtD
Alprazolam—Influenza—Doxorubicin—pancreatic cancer	0.000233	0.000942	CcSEcCtD
Alprazolam—Pollakiuria—Epirubicin—pancreatic cancer	0.000232	0.000941	CcSEcCtD
Alprazolam—Body temperature increased—Fluorouracil—pancreatic cancer	0.000232	0.00094	CcSEcCtD
Alprazolam—Palpitations—Docetaxel—pancreatic cancer	0.000229	0.00093	CcSEcCtD
Alprazolam—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000229	0.000929	CcSEcCtD
Alprazolam—Weight increased—Epirubicin—pancreatic cancer	0.000229	0.000927	CcSEcCtD
Alprazolam—Loss of consciousness—Docetaxel—pancreatic cancer	0.000228	0.000924	CcSEcCtD
Alprazolam—Weight decreased—Epirubicin—pancreatic cancer	0.000227	0.000921	CcSEcCtD
Alprazolam—Hypersensitivity—Irinotecan—pancreatic cancer	0.000226	0.000915	CcSEcCtD
Alprazolam—Convulsion—Docetaxel—pancreatic cancer	0.000225	0.000911	CcSEcCtD
Alprazolam—Infestation—Epirubicin—pancreatic cancer	0.000224	0.000908	CcSEcCtD
Alprazolam—Drowsiness—Epirubicin—pancreatic cancer	0.000224	0.000908	CcSEcCtD
Alprazolam—Infestation NOS—Epirubicin—pancreatic cancer	0.000224	0.000908	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000222	0.0009	CcSEcCtD
Alprazolam—Arthralgia—Docetaxel—pancreatic cancer	0.000221	0.000895	CcSEcCtD
Alprazolam—Myalgia—Docetaxel—pancreatic cancer	0.000221	0.000895	CcSEcCtD
Alprazolam—Chest pain—Docetaxel—pancreatic cancer	0.000221	0.000895	CcSEcCtD
Alprazolam—Nausea—Sunitinib—pancreatic cancer	0.000221	0.000895	CcSEcCtD
Alprazolam—Asthenia—Irinotecan—pancreatic cancer	0.00022	0.000891	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00022	0.000889	CcSEcCtD
Alprazolam—Jaundice—Epirubicin—pancreatic cancer	0.000218	0.000885	CcSEcCtD
Alprazolam—Dysuria—Doxorubicin—pancreatic cancer	0.000217	0.000881	CcSEcCtD
Alprazolam—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000216	0.000876	CcSEcCtD
Alprazolam—Dry mouth—Docetaxel—pancreatic cancer	0.000216	0.000876	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000216	0.000876	CcSEcCtD
Alprazolam—Sweating—Epirubicin—pancreatic cancer	0.000215	0.00087	CcSEcCtD
Alprazolam—Pollakiuria—Doxorubicin—pancreatic cancer	0.000215	0.00087	CcSEcCtD
Alprazolam—Asthenia—Gemcitabine—pancreatic cancer	0.000214	0.000868	CcSEcCtD
Alprazolam—Confusional state—Docetaxel—pancreatic cancer	0.000214	0.000866	CcSEcCtD
Alprazolam—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000212	0.00086	CcSEcCtD
Alprazolam—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000212	0.000859	CcSEcCtD
Alprazolam—Oedema—Docetaxel—pancreatic cancer	0.000212	0.000858	CcSEcCtD
Alprazolam—Weight increased—Doxorubicin—pancreatic cancer	0.000212	0.000857	CcSEcCtD
Alprazolam—Epistaxis—Epirubicin—pancreatic cancer	0.000211	0.000856	CcSEcCtD
Alprazolam—Pruritus—Gemcitabine—pancreatic cancer	0.000211	0.000856	CcSEcCtD
Alprazolam—Infection—Docetaxel—pancreatic cancer	0.000211	0.000853	CcSEcCtD
Alprazolam—Weight decreased—Doxorubicin—pancreatic cancer	0.00021	0.000852	CcSEcCtD
Alprazolam—Diarrhoea—Irinotecan—pancreatic cancer	0.00021	0.00085	CcSEcCtD
Alprazolam—Shock—Docetaxel—pancreatic cancer	0.000208	0.000845	CcSEcCtD
Alprazolam—Nervous system disorder—Docetaxel—pancreatic cancer	0.000208	0.000842	CcSEcCtD
Alprazolam—Pruritus—Fluorouracil—pancreatic cancer	0.000208	0.000841	CcSEcCtD
Alprazolam—Drowsiness—Doxorubicin—pancreatic cancer	0.000207	0.00084	CcSEcCtD
Alprazolam—Infestation NOS—Doxorubicin—pancreatic cancer	0.000207	0.00084	CcSEcCtD
Alprazolam—Infestation—Doxorubicin—pancreatic cancer	0.000207	0.00084	CcSEcCtD
Alprazolam—Tachycardia—Docetaxel—pancreatic cancer	0.000207	0.000838	CcSEcCtD
Alprazolam—Skin disorder—Docetaxel—pancreatic cancer	0.000206	0.000834	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000206	0.000833	CcSEcCtD
Alprazolam—Diarrhoea—Gemcitabine—pancreatic cancer	0.000204	0.000828	CcSEcCtD
Alprazolam—Dizziness—Irinotecan—pancreatic cancer	0.000203	0.000821	CcSEcCtD
Alprazolam—Jaundice—Doxorubicin—pancreatic cancer	0.000202	0.000819	CcSEcCtD
Alprazolam—Anorexia—Docetaxel—pancreatic cancer	0.000202	0.000818	CcSEcCtD
Alprazolam—Hepatitis—Epirubicin—pancreatic cancer	0.000201	0.000815	CcSEcCtD
Alprazolam—Diarrhoea—Fluorouracil—pancreatic cancer	0.000201	0.000814	CcSEcCtD
Alprazolam—Hypoaesthesia—Epirubicin—pancreatic cancer	0.0002	0.000811	CcSEcCtD
Alprazolam—Sweating—Doxorubicin—pancreatic cancer	0.000199	0.000805	CcSEcCtD
Alprazolam—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000199	0.000805	CcSEcCtD
Alprazolam—Oedema peripheral—Epirubicin—pancreatic cancer	0.000198	0.000803	CcSEcCtD
Alprazolam—Hypotension—Docetaxel—pancreatic cancer	0.000198	0.000802	CcSEcCtD
Alprazolam—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000198	0.000801	CcSEcCtD
Alprazolam—Urethral disorder—Epirubicin—pancreatic cancer	0.000197	0.000799	CcSEcCtD
Alprazolam—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000196	0.000794	CcSEcCtD
Alprazolam—Epistaxis—Doxorubicin—pancreatic cancer	0.000196	0.000792	CcSEcCtD
Alprazolam—Vomiting—Irinotecan—pancreatic cancer	0.000195	0.00079	CcSEcCtD
Alprazolam—Dizziness—Fluorouracil—pancreatic cancer	0.000194	0.000787	CcSEcCtD
Alprazolam—Rash—Irinotecan—pancreatic cancer	0.000193	0.000783	CcSEcCtD
Alprazolam—Dermatitis—Irinotecan—pancreatic cancer	0.000193	0.000782	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000193	0.000782	CcSEcCtD
Alprazolam—Headache—Irinotecan—pancreatic cancer	0.000192	0.000778	CcSEcCtD
Alprazolam—Insomnia—Docetaxel—pancreatic cancer	0.000192	0.000776	CcSEcCtD
Alprazolam—Paraesthesia—Docetaxel—pancreatic cancer	0.00019	0.000771	CcSEcCtD
Alprazolam—Erythema multiforme—Epirubicin—pancreatic cancer	0.00019	0.000771	CcSEcCtD
Alprazolam—Vomiting—Gemcitabine—pancreatic cancer	0.00019	0.000769	CcSEcCtD
Alprazolam—Dyspnoea—Docetaxel—pancreatic cancer	0.000189	0.000765	CcSEcCtD
Alprazolam—Somnolence—Docetaxel—pancreatic cancer	0.000188	0.000763	CcSEcCtD
Alprazolam—Rash—Gemcitabine—pancreatic cancer	0.000188	0.000763	CcSEcCtD
Alprazolam—Dermatitis—Gemcitabine—pancreatic cancer	0.000188	0.000762	CcSEcCtD
Alprazolam—Eye disorder—Epirubicin—pancreatic cancer	0.000188	0.000762	CcSEcCtD
Alprazolam—Tinnitus—Epirubicin—pancreatic cancer	0.000188	0.00076	CcSEcCtD
Alprazolam—Headache—Gemcitabine—pancreatic cancer	0.000187	0.000758	CcSEcCtD
Alprazolam—Cardiac disorder—Epirubicin—pancreatic cancer	0.000187	0.000756	CcSEcCtD
Alprazolam—Vomiting—Fluorouracil—pancreatic cancer	0.000187	0.000756	CcSEcCtD
Alprazolam—Dyspepsia—Docetaxel—pancreatic cancer	0.000187	0.000756	CcSEcCtD
Alprazolam—Hepatitis—Doxorubicin—pancreatic cancer	0.000186	0.000754	CcSEcCtD
Alprazolam—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000185	0.00075	CcSEcCtD
Alprazolam—Rash—Fluorouracil—pancreatic cancer	0.000185	0.00075	CcSEcCtD
Alprazolam—Dermatitis—Fluorouracil—pancreatic cancer	0.000185	0.000749	CcSEcCtD
Alprazolam—Decreased appetite—Docetaxel—pancreatic cancer	0.000184	0.000746	CcSEcCtD
Alprazolam—Headache—Fluorouracil—pancreatic cancer	0.000184	0.000745	CcSEcCtD
Alprazolam—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000184	0.000745	CcSEcCtD
Alprazolam—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000183	0.000743	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000183	0.000741	CcSEcCtD
Alprazolam—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000183	0.000741	CcSEcCtD
Alprazolam—Fatigue—Docetaxel—pancreatic cancer	0.000183	0.00074	CcSEcCtD
Alprazolam—Angiopathy—Epirubicin—pancreatic cancer	0.000183	0.000739	CcSEcCtD
Alprazolam—Urethral disorder—Doxorubicin—pancreatic cancer	0.000182	0.000739	CcSEcCtD
Alprazolam—Nausea—Irinotecan—pancreatic cancer	0.000182	0.000738	CcSEcCtD
Alprazolam—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000181	0.000735	CcSEcCtD
Alprazolam—Constipation—Docetaxel—pancreatic cancer	0.000181	0.000734	CcSEcCtD
Alprazolam—Chills—Epirubicin—pancreatic cancer	0.000181	0.000731	CcSEcCtD
Alprazolam—Nausea—Gemcitabine—pancreatic cancer	0.000177	0.000719	CcSEcCtD
Alprazolam—Mental disorder—Epirubicin—pancreatic cancer	0.000176	0.000714	CcSEcCtD
Alprazolam—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000176	0.000713	CcSEcCtD
Alprazolam—Malnutrition—Epirubicin—pancreatic cancer	0.000175	0.000709	CcSEcCtD
Alprazolam—Feeling abnormal—Docetaxel—pancreatic cancer	0.000175	0.000707	CcSEcCtD
Alprazolam—Nausea—Fluorouracil—pancreatic cancer	0.000174	0.000706	CcSEcCtD
Alprazolam—Eye disorder—Doxorubicin—pancreatic cancer	0.000174	0.000705	CcSEcCtD
Alprazolam—Tinnitus—Doxorubicin—pancreatic cancer	0.000174	0.000703	CcSEcCtD
Alprazolam—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000173	0.000702	CcSEcCtD
Alprazolam—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000173	0.0007	CcSEcCtD
Alprazolam—Tension—Epirubicin—pancreatic cancer	0.000172	0.000696	CcSEcCtD
Alprazolam—Nervousness—Epirubicin—pancreatic cancer	0.00017	0.000689	CcSEcCtD
Alprazolam—Back pain—Epirubicin—pancreatic cancer	0.000169	0.000686	CcSEcCtD
Alprazolam—Angiopathy—Doxorubicin—pancreatic cancer	0.000169	0.000684	CcSEcCtD
Alprazolam—Muscle spasms—Epirubicin—pancreatic cancer	0.000168	0.000682	CcSEcCtD
Alprazolam—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000168	0.00068	CcSEcCtD
Alprazolam—Body temperature increased—Docetaxel—pancreatic cancer	0.000168	0.000679	CcSEcCtD
Alprazolam—Abdominal pain—Docetaxel—pancreatic cancer	0.000168	0.000679	CcSEcCtD
Alprazolam—Chills—Doxorubicin—pancreatic cancer	0.000167	0.000677	CcSEcCtD
Alprazolam—Vision blurred—Epirubicin—pancreatic cancer	0.000165	0.000669	CcSEcCtD
Alprazolam—Mental disorder—Doxorubicin—pancreatic cancer	0.000163	0.000661	CcSEcCtD
Alprazolam—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000162	0.000658	CcSEcCtD
Alprazolam—Malnutrition—Doxorubicin—pancreatic cancer	0.000162	0.000656	CcSEcCtD
Alprazolam—Agitation—Epirubicin—pancreatic cancer	0.000161	0.000652	CcSEcCtD
Alprazolam—Tension—Doxorubicin—pancreatic cancer	0.000159	0.000644	CcSEcCtD
Alprazolam—Malaise—Epirubicin—pancreatic cancer	0.000158	0.00064	CcSEcCtD
Alprazolam—Nervousness—Doxorubicin—pancreatic cancer	0.000157	0.000638	CcSEcCtD
Alprazolam—Vertigo—Epirubicin—pancreatic cancer	0.000157	0.000637	CcSEcCtD
Alprazolam—Syncope—Epirubicin—pancreatic cancer	0.000157	0.000636	CcSEcCtD
Alprazolam—Back pain—Doxorubicin—pancreatic cancer	0.000157	0.000635	CcSEcCtD
Alprazolam—Hypersensitivity—Docetaxel—pancreatic cancer	0.000156	0.000632	CcSEcCtD
Alprazolam—Muscle spasms—Doxorubicin—pancreatic cancer	0.000156	0.000631	CcSEcCtD
Alprazolam—Palpitations—Epirubicin—pancreatic cancer	0.000155	0.000627	CcSEcCtD
Alprazolam—Loss of consciousness—Epirubicin—pancreatic cancer	0.000154	0.000624	CcSEcCtD
Alprazolam—Vision blurred—Doxorubicin—pancreatic cancer	0.000153	0.000619	CcSEcCtD
Alprazolam—Asthenia—Docetaxel—pancreatic cancer	0.000152	0.000616	CcSEcCtD
Alprazolam—Convulsion—Epirubicin—pancreatic cancer	0.000152	0.000615	CcSEcCtD
Alprazolam—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00015	0.000609	CcSEcCtD
Alprazolam—Pruritus—Docetaxel—pancreatic cancer	0.00015	0.000607	CcSEcCtD
Alprazolam—Chest pain—Epirubicin—pancreatic cancer	0.000149	0.000604	CcSEcCtD
Alprazolam—Arthralgia—Epirubicin—pancreatic cancer	0.000149	0.000604	CcSEcCtD
Alprazolam—Myalgia—Epirubicin—pancreatic cancer	0.000149	0.000604	CcSEcCtD
Alprazolam—Agitation—Doxorubicin—pancreatic cancer	0.000149	0.000603	CcSEcCtD
Alprazolam—Anxiety—Epirubicin—pancreatic cancer	0.000149	0.000602	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000148	0.0006	CcSEcCtD
Alprazolam—Discomfort—Epirubicin—pancreatic cancer	0.000147	0.000597	CcSEcCtD
Alprazolam—Malaise—Doxorubicin—pancreatic cancer	0.000146	0.000592	CcSEcCtD
Alprazolam—Dry mouth—Epirubicin—pancreatic cancer	0.000146	0.000591	CcSEcCtD
Alprazolam—Vertigo—Doxorubicin—pancreatic cancer	0.000146	0.00059	CcSEcCtD
Alprazolam—Syncope—Doxorubicin—pancreatic cancer	0.000145	0.000589	CcSEcCtD
Alprazolam—Diarrhoea—Docetaxel—pancreatic cancer	0.000145	0.000587	CcSEcCtD
Alprazolam—Confusional state—Epirubicin—pancreatic cancer	0.000144	0.000584	CcSEcCtD
Alprazolam—Palpitations—Doxorubicin—pancreatic cancer	0.000143	0.00058	CcSEcCtD
Alprazolam—Oedema—Epirubicin—pancreatic cancer	0.000143	0.000579	CcSEcCtD
Alprazolam—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000142	0.000577	CcSEcCtD
Alprazolam—Infection—Epirubicin—pancreatic cancer	0.000142	0.000575	CcSEcCtD
Alprazolam—Shock—Epirubicin—pancreatic cancer	0.000141	0.00057	CcSEcCtD
Alprazolam—Convulsion—Doxorubicin—pancreatic cancer	0.00014	0.000569	CcSEcCtD
Alprazolam—Nervous system disorder—Epirubicin—pancreatic cancer	0.00014	0.000568	CcSEcCtD
Alprazolam—Dizziness—Docetaxel—pancreatic cancer	0.00014	0.000568	CcSEcCtD
Alprazolam—Tachycardia—Epirubicin—pancreatic cancer	0.000139	0.000565	CcSEcCtD
Alprazolam—Skin disorder—Epirubicin—pancreatic cancer	0.000139	0.000562	CcSEcCtD
Alprazolam—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000138	0.00056	CcSEcCtD
Alprazolam—Arthralgia—Doxorubicin—pancreatic cancer	0.000138	0.000559	CcSEcCtD
Alprazolam—Myalgia—Doxorubicin—pancreatic cancer	0.000138	0.000559	CcSEcCtD
Alprazolam—Chest pain—Doxorubicin—pancreatic cancer	0.000138	0.000559	CcSEcCtD
Alprazolam—Anxiety—Doxorubicin—pancreatic cancer	0.000137	0.000557	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000137	0.000555	CcSEcCtD
Alprazolam—Discomfort—Doxorubicin—pancreatic cancer	0.000136	0.000552	CcSEcCtD
Alprazolam—Anorexia—Epirubicin—pancreatic cancer	0.000136	0.000552	CcSEcCtD
Alprazolam—Dry mouth—Doxorubicin—pancreatic cancer	0.000135	0.000547	CcSEcCtD
Alprazolam—Vomiting—Docetaxel—pancreatic cancer	0.000135	0.000546	CcSEcCtD
Alprazolam—Rash—Docetaxel—pancreatic cancer	0.000134	0.000541	CcSEcCtD
Alprazolam—Hypotension—Epirubicin—pancreatic cancer	0.000134	0.000541	CcSEcCtD
Alprazolam—Dermatitis—Docetaxel—pancreatic cancer	0.000133	0.000541	CcSEcCtD
Alprazolam—Confusional state—Doxorubicin—pancreatic cancer	0.000133	0.00054	CcSEcCtD
Alprazolam—Headache—Docetaxel—pancreatic cancer	0.000133	0.000538	CcSEcCtD
Alprazolam—Oedema—Doxorubicin—pancreatic cancer	0.000132	0.000536	CcSEcCtD
Alprazolam—Infection—Doxorubicin—pancreatic cancer	0.000131	0.000532	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00013	0.000528	CcSEcCtD
Alprazolam—Shock—Doxorubicin—pancreatic cancer	0.00013	0.000527	CcSEcCtD
Alprazolam—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00013	0.000525	CcSEcCtD
Alprazolam—Insomnia—Epirubicin—pancreatic cancer	0.000129	0.000524	CcSEcCtD
Alprazolam—Tachycardia—Doxorubicin—pancreatic cancer	0.000129	0.000523	CcSEcCtD
Alprazolam—Skin disorder—Doxorubicin—pancreatic cancer	0.000128	0.00052	CcSEcCtD
Alprazolam—Paraesthesia—Epirubicin—pancreatic cancer	0.000128	0.00052	CcSEcCtD
Alprazolam—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000128	0.000518	CcSEcCtD
Alprazolam—Dyspnoea—Epirubicin—pancreatic cancer	0.000127	0.000516	CcSEcCtD
Alprazolam—Somnolence—Epirubicin—pancreatic cancer	0.000127	0.000515	CcSEcCtD
Alprazolam—Anorexia—Doxorubicin—pancreatic cancer	0.000126	0.000511	CcSEcCtD
Alprazolam—Nausea—Docetaxel—pancreatic cancer	0.000126	0.00051	CcSEcCtD
Alprazolam—Dyspepsia—Epirubicin—pancreatic cancer	0.000126	0.00051	CcSEcCtD
Alprazolam—Decreased appetite—Epirubicin—pancreatic cancer	0.000124	0.000503	CcSEcCtD
Alprazolam—Hypotension—Doxorubicin—pancreatic cancer	0.000124	0.000501	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000123	0.0005	CcSEcCtD
Alprazolam—Fatigue—Epirubicin—pancreatic cancer	0.000123	0.000499	CcSEcCtD
Alprazolam—Constipation—Epirubicin—pancreatic cancer	0.000122	0.000495	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00012	0.000488	CcSEcCtD
Alprazolam—Insomnia—Doxorubicin—pancreatic cancer	0.00012	0.000485	CcSEcCtD
Alprazolam—Paraesthesia—Doxorubicin—pancreatic cancer	0.000119	0.000481	CcSEcCtD
Alprazolam—Dyspnoea—Doxorubicin—pancreatic cancer	0.000118	0.000478	CcSEcCtD
Alprazolam—Feeling abnormal—Epirubicin—pancreatic cancer	0.000118	0.000477	CcSEcCtD
Alprazolam—Somnolence—Doxorubicin—pancreatic cancer	0.000118	0.000476	CcSEcCtD
Alprazolam—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000117	0.000473	CcSEcCtD
Alprazolam—Dyspepsia—Doxorubicin—pancreatic cancer	0.000116	0.000472	CcSEcCtD
Alprazolam—Decreased appetite—Doxorubicin—pancreatic cancer	0.000115	0.000466	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000114	0.000463	CcSEcCtD
Alprazolam—Fatigue—Doxorubicin—pancreatic cancer	0.000114	0.000462	CcSEcCtD
Alprazolam—Urticaria—Epirubicin—pancreatic cancer	0.000114	0.00046	CcSEcCtD
Alprazolam—Constipation—Doxorubicin—pancreatic cancer	0.000113	0.000458	CcSEcCtD
Alprazolam—Abdominal pain—Epirubicin—pancreatic cancer	0.000113	0.000458	CcSEcCtD
Alprazolam—Body temperature increased—Epirubicin—pancreatic cancer	0.000113	0.000458	CcSEcCtD
Alprazolam—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000109	0.000441	CcSEcCtD
Alprazolam—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000108	0.000438	CcSEcCtD
Alprazolam—Hypersensitivity—Epirubicin—pancreatic cancer	0.000105	0.000427	CcSEcCtD
Alprazolam—Urticaria—Doxorubicin—pancreatic cancer	0.000105	0.000426	CcSEcCtD
Alprazolam—Body temperature increased—Doxorubicin—pancreatic cancer	0.000105	0.000424	CcSEcCtD
Alprazolam—Abdominal pain—Doxorubicin—pancreatic cancer	0.000105	0.000424	CcSEcCtD
Alprazolam—Asthenia—Epirubicin—pancreatic cancer	0.000103	0.000415	CcSEcCtD
Alprazolam—Pruritus—Epirubicin—pancreatic cancer	0.000101	0.00041	CcSEcCtD
Alprazolam—Diarrhoea—Epirubicin—pancreatic cancer	9.78e-05	0.000396	CcSEcCtD
Alprazolam—Hypersensitivity—Doxorubicin—pancreatic cancer	9.74e-05	0.000395	CcSEcCtD
Alprazolam—Asthenia—Doxorubicin—pancreatic cancer	9.49e-05	0.000384	CcSEcCtD
Alprazolam—Dizziness—Epirubicin—pancreatic cancer	9.45e-05	0.000383	CcSEcCtD
Alprazolam—Pruritus—Doxorubicin—pancreatic cancer	9.36e-05	0.000379	CcSEcCtD
Alprazolam—Vomiting—Epirubicin—pancreatic cancer	9.09e-05	0.000368	CcSEcCtD
Alprazolam—Diarrhoea—Doxorubicin—pancreatic cancer	9.05e-05	0.000367	CcSEcCtD
Alprazolam—Rash—Epirubicin—pancreatic cancer	9.01e-05	0.000365	CcSEcCtD
Alprazolam—Dermatitis—Epirubicin—pancreatic cancer	9e-05	0.000365	CcSEcCtD
Alprazolam—Headache—Epirubicin—pancreatic cancer	8.95e-05	0.000363	CcSEcCtD
Alprazolam—Dizziness—Doxorubicin—pancreatic cancer	8.75e-05	0.000354	CcSEcCtD
Alprazolam—Nausea—Epirubicin—pancreatic cancer	8.49e-05	0.000344	CcSEcCtD
Alprazolam—Vomiting—Doxorubicin—pancreatic cancer	8.41e-05	0.000341	CcSEcCtD
Alprazolam—Rash—Doxorubicin—pancreatic cancer	8.34e-05	0.000338	CcSEcCtD
Alprazolam—Dermatitis—Doxorubicin—pancreatic cancer	8.33e-05	0.000337	CcSEcCtD
Alprazolam—Headache—Doxorubicin—pancreatic cancer	8.29e-05	0.000336	CcSEcCtD
Alprazolam—Nausea—Doxorubicin—pancreatic cancer	7.86e-05	0.000318	CcSEcCtD
